Snapshot A radiograph of a 25-year-old patient of West Indian origin shows bilateral hip deformities with increased density of the bone. Her hemoglobin electrophoresis reveals predominantly Hgb S, slightly increased Hgb F, and no Hgb A. Introduction An autosomal recessive disorder due to a mutation in hemoglobin β-chain Glu to Val at position 6 Hgb S tetramers polymerize causing sickling of deoxygenated RBCs requires > 90% HbS to sickle in systemic vasculature exception is in the renal papilla where oxygen tension is low enough to induce sickling Homozygotes have systemic / hematologic disease Heterozygotes are usually asymptomatic and have some resistance to malaria, painless hematuria with the correct family history is a sign of the diagnosis. Blacks are most commonly affected Acute vaso-occlusive sickling episodes are often precipitated by infection acidosis hypoxia dehydration HbF is protective for first several months of life Presentation Presents with sickle cell vaso-occlusive crises chest pain bone pain fever stroke priapism abdominal pain autosplenectomy gallstones dactylitis painful swelling of the hands and feet up to 50% of children under three will develop Physical exam splenomegaly jaundice pallor bone / joint tenderness Evaluation Labs normocytic or microcytic anemia ↑ reticulocyte count low in aplastic crises ↓ haptoglobin Histology peripheral blood smear shows sickling, Howell-Jolly bodies no sickling seen in sickle cell trait bone marrow smear is hypercellular Imaging check CXR for chest syndrome hair-on-end/crew cut skull XR due to expansion of marrow as a result of extramedullary hematopoiesis Hemoglobin electrophoresis sickle cell disease HbS, ↑ HbF, no HbA sickle cell trait HbS, ↓ HbA Metabisulfite screen induces sickling at any HbS concentration positive in sickle cell trait and sickle cell anemia Treatment Treat acute attacks with hydration oxygen analgesia Medical hydroxyurea decreases frequency and severity of crises by increasing HbF production gardos channel blockers decreases potassium efflux and therefore RBC dehydration by inhibiting calcium-activated potassium channels (Gardos channels) pneumococcal vaccine to prevent pneumococcal sepsis be alert for infection by encapsulated organisms due to functional asplenia Prognosis, Prevention, and Complications Infection Salmonella paratyphi osteomyelitis aplastic anemia/crisis with parvovirus B19 infection will have low reticulocyte count Splenic sequestration acute painful enlargement of spleen due to trapping of red blood cells can cause symptoms of hypovolemia if prolonged Acute chest syndrome vaso-occlusion of pulmonary vasculature most common cause of death in SC patients Avascular necrosis of the femoral head MI Gallbladder disease ↑ RBC turnover results in increased bilirubin in the bile favorable environment for stone formation Renal papillary necrosis Retinopathy
QUESTIONS 1 of 9 1 2 3 4 5 6 7 8 9 Previous Next Lab Values Blood Hematologic Cerebrospinal Sweat, Urine, and BMI Blood, Plasma, Serum Reference Range ALT 8-20 U/L Amylase, serum 25-125 U/L AST 8-20 U/L Bilirubin, serum (adult) Total // Direct 0.1-1.0 mg/dL // 0.0-0.3 mg/dL Calcium, serum (Ca2+) 8.4-10.2 mg/dL Cholesterol, serum Rec: < 200 mg/dL Cortisol, serum 0800 h: 5-23 μg/dL //1600 h: 3-15 μg/dL 2000 h: ≤ 50% of 0800 h Creatine kinase, serum Male: 25-90 U/LFemale: 10-70 U/L Creatinine, serum 0.6-1.2 mg/dL Electrolytes, serum Sodium (Na+) 136-145 mEq/L Chloride (Cl-) 95-105 mEq/L Potassium (K+) 3.5-5.0 mEq/L Bicarbonate (HCO3-) 22-28 mEq/L Magnesium (Mg2+) 1.5-2.0 mEq/L Estriol, total, serum (in pregnancy) 24-28 wks // 32-36 wks 30-170 ng/mL // 60-280 ng/mL 28-32 wk // 36-40 wks 40-220 ng/mL // 80-350 ng/mL Ferritin, serum Male: 15-200 ng/mLFemale: 12-150 ng/mL Follicle-stimulating hormone, serum/plasma Male: 4-25 mIU/mL Female: premenopause: 4-30 mIU/mL midcycle peak: 10-90 mIU/mL postmenopause: 40-250 pH 7.35-7.45 PCO2 33-45 mmHg PO2 75-105 mmHg Glucose, serum Fasting: 70-110 mg/dL2-h postprandial:<120 mg/dL Growth hormone - arginine stimulation Fasting: <5 ng/mLProvocative stimuli: > 7ng/mL Immunoglobulins, serum IgA 76-390 mg/dL IgE 0-380 IU/mL IgG 650-1500 mg/dL IgM 40-345 mg/dL Iron 50-170 μg/dL Lactate dehydrogenase, serum 45-90 U/L Luteinizing hormone, serum/plasma Male: 6-23 mIU/mL Female: follicular phase: 5-30 mIU/mL midcycle: 75-150 mIU/mL postmenopause 30-200 mIU/mL Osmolality, serum 275-295 mOsmol/kd H2O Parathyroid hormone, serume, N-terminal 230-630 pg/mL Phosphatase (alkaline), serum (p-NPP at 30° C) 20-70 U/L Phosphorus (inorganic), serum 3.0-4.5 mg/dL Prolactin, serum (hPRL) < 20 ng/mL Proteins, serum Total (recumbent) 6.0-7.8 g/dL Albumin 3.5-5.5 g/dL Globulin 2.3-3.5 g/dL Thyroid-stimulating hormone, serum or plasma .5-5.0 μU/mL Thyroidal iodine (123I) uptake 8%-30% of administered dose/24h Thyroxine (T4), serum 5-12 μg/dL Triglycerides, serum 35-160 mg/dL Triiodothyronine (T3), serum (RIA) 115-190 ng/dL Triiodothyronine (T3) resin uptake 25%-35% Urea nitrogen, serum 7-18 mg/dL Uric acid, serum 3.0-8.2 mg/dL Hematologic Reference Range Bleeding time 2-7 minutes Erythrocyte count Male: 4.3-5.9 million/mm3Female: 3.5-5.5 million mm3 Erythrocyte sedimentation rate (Westergren) Male: 0-15 mm/hFemale: 0-20 mm/h Hematocrit Male: 41%-53%Female: 36%-46% Hemoglobin A1c ≤ 6 % Hemoglobin, blood Male: 13.5-17.5 g/dLFemale: 12.0-16.0 g/dL Hemoglobin, plasma 1-4 mg/dL Leukocyte count and differential Leukocyte count 4,500-11,000/mm3 Segmented neutrophils 54%-62% Bands 3%-5% Eosinophils 1%-3% Basophils 0%-0.75% Lymphocytes 25%-33% Monocytes 3%-7% Mean corpuscular hemoglobin 25.4-34.6 pg/cell Mean corpuscular hemoglobin concentration 31%-36% Hb/cell Mean corpuscular volume 80-100 μm3 Partial thromboplastin time (activated) 25-40 seconds Platelet count 150,000-400,000/mm3 Prothrombin time 11-15 seconds Reticulocyte count 0.5%-1.5% of red cells Thrombin time < 2 seconds deviation from control Volume Plasma Male: 25-43 mL/kgFemale: 28-45 mL/kg Red cell Male: 20-36 mL/kgFemale: 19-31 mL/kg Cerebrospinal Fluid Reference Range Cell count 0-5/mm3 Chloride 118-132 mEq/L Gamma globulin 3%-12% total proteins Glucose 40-70 mg/dL Pressure 70-180 mm H2O Proteins, total < 40 mg/dL Sweat Reference Range Chloride 0-35 mmol/L Urine Calcium 100-300 mg/24 h Chloride Varies with intake Creatinine clearance Male: 97-137 mL/minFemale: 88-128 mL/min Estriol, total (in pregnancy) 30 wks 6-18 mg/24 h 35 wks 9-28 mg/24 h 40 wks 13-42 mg/24 h 17-Hydroxycorticosteroids Male: 3.0-10.0 mg/24 hFemale: 2.0-8.0 mg/24 h 17-Ketosteroids, total Male: 8-20 mg/24 hFemale: 6-15 mg/24 h Osmolality 50-1400 mOsmol/kg H2O Oxalate 8-40 μg/mL Potassium Varies with diet Proteins, total < 150 mg/24 h Sodium Varies with diet Uric acid Varies with diet Body Mass Index (BMI) Adult: 19-25 kg/m2 Calculator ( ) xy AC 7 8 9 ÷ 4 5 6 × 1 2 3 - 0 . = + Sorry, this question is for PEAK Premium Subscribers only Upgrade to PEAK (M1.HE.4666) A 24-year-old African American male with sickle cell disease has been followed by a hematologist since infancy. Two years ago, he was started on hydroxyurea for frequent pain crises but has not achieved good control. The addition of a Gardos channel blocking agent is being considered. What is the mechanism of action of this class of medications? Review Topic QID: 107109 1 Prevents RBC dehydration by inhibiting K+ efflux 50% (8/16) 2 Increases production of hemoglobin F 12% (2/16) 3 Prevents dehydration of RBCs by inhibiting Ca2+ efflux 6% (1/16) 4 Encourages alkalinization of the blood by facilitating H+/K+ antiporter activity 12% (2/16) 5 Increases water diffusion by increasing activity of aquaporin-1 receptors 0% (0/16) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 1 Sorry, this question is for PEAK Premium Subscribers only Upgrade to PEAK (M1.HE.74) A 5-year-old African American boy presents with extreme abdominal pain. He has a history of several such episodes, as well as acute episodes of extreme bone pain. He has previously presented with the findings illustrated in Figure A. A peripheral blood smear is obtained, and is shown in Figure B. What is the most likely mechanism responsible for this patient's disorder? Review Topic QID: 106635 FIGURES: A B 1 Tri-nucleotide repeat amplification 2% (3/124) 2 Mutation in the gene coding for hemoglobin-alpha 3% (4/124) 3 Point mutation at the 6th position of the ß-hemoglobin chain 87% (108/124) 4 Increased levels of hemoglobin-F 2% (3/124) 5 Reduced levels of folic acid 2% (2/124) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 3 (M1.HE.74) A 4-year-old African American boy presents with extreme abdominal pain. He has had similar episodes in the past. A peripheral smear is obtained, and shows the findings illustrated in Figure A. Which of the following is a mechanism which can precipitate this condition? Review Topic QID: 106614 FIGURES: A 1 Elevated cellular pH 17% (13/75) 2 Elevated 2,3-diphosphoglycerate 60% (45/75) 3 Elevated arterial oxygen concentration 4% (3/75) 4 Elevated hemoglobin F levels 8% (6/75) 5 Travel from high to low elevation geographical area 9% (7/75) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 2 (M1.HE.52) A 17-year-old African-American male presents to his family physician after noticing red-tinged urine the week before, when he was suffering from a cold. The patient states that he had experienced that before. His father is with him and says that this happens to him on occasion as well. What is the most likely diagnosis for this patient? Review Topic QID: 104499 1 Acute cystitis 0% (0/16) 2 Acute interstitial nephritis 0% (0/16) 3 Sickle cell trait 50% (8/16) 4 Acute glomerulonephritis 6% (1/16) 5 Hemophilia 38% (6/16) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 3 (M1.HE.11) Patients with the diagnosis of sickle cell anemia make a specific type of hemoglobin known as HgbS. This mutation results in the sickling of their red blood cells when exposed to inciting factors such as hypoxic conditions. Patients are often treated with hydroxyurea, which has which of the following direct effects on their hemoglobin physiology? Review Topic QID: 104651 1 Increases oxygen carrying capacity of hemoglobin 10% (9/94) 2 Decreases oxygen carrying capacity of hemoglobin 4% (4/94) 3 Increases levels of fetal hemoglobin (HgbF) 81% (76/94) 4 Decreases levels of HgbS 2% (2/94) 5 Decreases levels of fetal hemoglobin (HgbF) 2% (2/94) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 3 (M1.HE.33) A 7-year-old girl with a history of painful crises and impaired growth presents for evaluation of sickle cell disease. You perform hemoglobin gel electrophoresis, and diagnose her with homozygous sickle cell disease. Which of the gel electrophoresis lanes in the image is hers? Review Topic QID: 100098 FIGURES: A 1 Lane 2 3% (4/130) 2 Lane 3 2% (3/130) 3 Lane 4 84% (109/130) 4 Lane 6 6% (8/130) 5 Lane 7 3% (4/130) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 3 (M1.HE.86) An 8-year-old boy complains of extremity pain and difficulty "catching his breath" while running on the playground. His mother also reports that he complains of intermittent abdominal pain. Physical examination reveals splenomegaly. The patient's blood smear is shown in Figure A. What is the most likely mutation present? Review Topic QID: 100151 FIGURES: A 1 Deleted tryptophan 1% (1/129) 2 Deleted glycine 0% (0/129) 3 Glutamic acid to valine 70% (90/129) 4 Glutamine to valine 25% (32/129) 5 Inserted lysine 2% (2/129) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 3
Sickle Cell Disease Hematology - Sickle Cell Anemia - Treatment Consult Description of the pathophysiology and clinical manifestations of Sickle Cell Di... 10/13/2013 29 views